EGFR-mutated NSCLC

Could J&J’s Rybrevant-based combo disrupt AstraZeneca’s Tagrisso in lung cancer faceoff?
Medical Marketing and Media
Thu, 10/19/23 - 11:29 am
JNJ
Rybrevant
AstraZeneca
Tagrisso
EGFR-mutated NSCLC
AstraZeneca's flagship Tagrisso helps lung cancer patients live longer in pivotal study
Endpoints
Fri, 08/9/19 - 10:28 am
AstraZeneca
Tagrisso
EGFR-mutated NSCLC